142 related articles for article (PubMed ID: 400737)
1. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
Sacca L; Hendler R; Sherwin RS
J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
[TBL] [Abstract][Full Text] [Related]
2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
3. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
Felig P; Wahren J; Hendler R
J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
[TBL] [Abstract][Full Text] [Related]
4. Physical training in juvenile diabetes.
Koivisto VA; Groop L
Ann Clin Res; 1982; 14 Suppl 34():74-9. PubMed ID: 6756276
[TBL] [Abstract][Full Text] [Related]
5. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
6. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
[TBL] [Abstract][Full Text] [Related]
7. The glucoregulatory response to intravenous glucose infusion in normal man: roles of insulin and glucose.
Saccà L; Vitale D; Cicala M; Trimarco B; Ungaro B
Metabolism; 1981 May; 30(5):457-61. PubMed ID: 6112655
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
Eigler N; Saccà L; Sherwin RS
J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
11. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
Ward WK; Best JD; Halter JB; Porte D
J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
[TBL] [Abstract][Full Text] [Related]
14. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
[TBL] [Abstract][Full Text] [Related]
15. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
[TBL] [Abstract][Full Text] [Related]
16. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
17. Control of hepatic glucose output by glucagon and insulin in the intact dog.
Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
[TBL] [Abstract][Full Text] [Related]
18. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
[TBL] [Abstract][Full Text] [Related]
20. Beta-endorphin inhibits glucose production in the conscious dog.
Radosevich PM; Williams PE; McRae JR; Lacy WW; Orth DN; Abumrad NN
J Clin Invest; 1984 Apr; 73(4):1237-41. PubMed ID: 6323537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
